A randomised trial comparing argon plasma coagulation (APC) and self-expanding metal stents (SEMS) in oesophageal cancer
ISRCTN | ISRCTN58821595 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN58821595 |
Secondary identifying numbers | N0077122803 |
- Submission date
- 12/09/2003
- Registration date
- 12/09/2003
- Last edited
- 22/09/2014
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr JG Freeman
Scientific
Scientific
Southern Derbyshire Acute Hospitals NHS Trust
Gastroenterology & Liver Unit
Derby City General Hospital
Uttoxeter Road
Derby
DE22 3NE
United Kingdom
Phone | +44 (0)1332 625532 |
---|
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Scientific title | |
Study objectives | To test the hypothesis that early stent insertion is superior to argon plasma coagulation of oesophageal cancer in the palliative treatment of malignant dysphagia. |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Cancer: oesophageal |
Intervention | Patients not eligible for surgery, presenting with dysphagia (score of >2) will be randomised to primary treatment with either APC or SEMS. Dysphagia management will be as per randomised arm until clinical indication to crossover. Where the stricture prevents passage of the scope into the stomach, through-the-scope balloon will be performed. Either APC or stenting will be used to overcome tumour obstruction of the oesophagus. Providing the patient is able to swallow liquids after the procedure, they will be discharged for reassessment at 1 week, at which stage a second treatment can be considered to achieve a dysphagia score of 2. If this is not achieved with two treatments, crossover to stenting should be considered. Those patients who have had successful APC will attend the endoscopy unit for repeat treatments at 4 weekly intervals unless dysphagia deems earlier intervention appropriate. Stent patients will be assessed at 1 week, then monthly with quality of life questionnaires in the clinic. Patients requiring further intervention after SEMS insertion due to overgrowth would be considered for re-stenting; those with tumour ingrowth would crossover to APC. Quality of life will be quantified using EORTC QLQ-C30 and QLQ-OES, prior to intervention and at 4 weekly intervals. Dysphagia scores will be recorded prior to primary intervention, at 1 week after intervention and at 4 weekly intervals. At randomisation, length and position to tumour, histology, disease staging, body mass index and Karnofsky performance score will be recorded. |
Intervention type | Other |
Primary outcome measure | 1. Comparison of reductions in dysphagia scores between the two groups 2. Comparison of quality of life scores between the two groups 3. Number of interventions per arm and consequent cost analysis |
Secondary outcome measures | Not provided at time of registration |
Overall study start date | 04/12/2002 |
Completion date | 04/12/2005 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Not Specified |
Sex | Not Specified |
Target number of participants | Not provided at time of registration |
Key inclusion criteria | Patients with oesophageal cancer who are not eligible for surgery following multi-disciplinary team discussion who are unable to swallow semi-solid food |
Key exclusion criteria | Not provided at time of registration |
Date of first enrolment | 04/12/2002 |
Date of final enrolment | 04/12/2005 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Southern Derbyshire Acute Hospitals NHS Trust
Derby
DE22 3NE
United Kingdom
DE22 3NE
United Kingdom
Sponsor information
Department of Health (UK)
Government
Government
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
Website | http://www.doh.gov.uk |
---|
Funders
Funder type
Government
Southern Derbyshire Acute Hospitals NHS Trust (UK)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |